Basis: Four-quarter free cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The free cash flow yield is N/A as of 2026-10-06T17:06:20.447Z.
Calculation as of: 2026-10-06T17:06:20.447Z.
Quote observation: 2026-10-06T17:05:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 4980e4284b6230c79d3dcd5f09fe919c7c05eb80d65ab6e095ba480293e97312
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FREE CASH FLOW YIELD
N/A
Canton Strategic Holdings Inc
Market Cap
$185.48M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$185.30M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$189.50M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$182.12M
Free Cash Flow Yield
N/A
TTM Avg
4.80%
3Y Avg
4.80%
5Y Avg
4.80%
Market Cap
$176.97M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$175.86M
Free Cash Flow Yield
N/A
TTM Avg
7.28%
3Y Avg
8.72%
5Y Avg
8.72%
Market Cap
$176.31M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | FREE CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Canton Strategic Holdings Inc (CNTN) | $185.48M | N/A | N/A | N/A | N/A |
| AN2 Therapeutics, Inc. (ANTX)vs › | $185.30M | N/A | N/A | N/A | N/A |
| Eledon Pharmaceuticals, Inc. (ELDN)vs › | $189.50M | N/A | N/A | N/A | N/A |
| Oramed Pharmaceuticals Inc. (ORMP)vs › | $182.12M | N/A | 4.80% | 4.80% | 4.80% |
| RxSight, Inc. (RXST)vs › | $192.08M | N/A | N/A | N/A | N/A |
| Yarrow Bioscience Inc (YARW)vs › | $176.97M | N/A | N/A | N/A | N/A |
| Journey Medical Corporation (DERM)vs › | $175.86M | N/A | 7.28% | 8.72% | 8.72% |
| Compass Therapeutics, Inc. (CMPX)vs › | $176.31M | N/A | N/A | N/A | N/A |
| Surrozen, Inc. (SRZN)vs › | $196.62M | N/A | N/A | N/A | N/A |
| ProQR Therapeutics N.V. (PRQR)vs › | $173.23M | N/A | 6.14% | 6.14% | 6.14% |
FCF Yield
N/A
Earnings Yield
N/A
Dividend Yield
N/A
Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100
How FCF Yield is used:
FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.
FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
